Skip to Main Content

Paper Details

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>â¿ </sup>: Under the Auspices of the EAU-ESMO Guidelines Committees.
Eur Urol
121
2020
Advanced and Variant Bladder Cancer, PARTICIPANTS, PATIENT, bladder cancer, health, metastatic disease, oligometastatic, patient
Author NameAffiliation
Theo M de ReijkeAmsterdam University Medical Centers, University of Amsterdam
Neeraj AgarwalHuntsman Cancer Institute, University of Utah (NCI-CCC)
Michel BollaGrenoble - Alpes University
Alberto BrigantiUrological Research Institute, Milan Vita-Salute University, San Raffaele Scientific Institute
Ananya ChoudhuryUniversity of Manchester, UK The Christie NHS Foundation Trust
Mark FrydenbergMonash University
Peter HoskinUniversity of Manchester, UK The Christie NHS Foundation Trust
Vincent KhooThe Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, University of Melbourne Monash University
James N'DowUniversity of Aberdeen, Aberdeen Royal Infirmary
Arnulf StenzlEberhard Karls University Tubingen
Baris TurkbeyNational Cancer Institute
Hendrik Van PoppelUniversity Hospitals Leuven
  • 1 - 12

Datasets

Release 1.2